Roger Becker
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 2
-
- Epigenetics and DNA Methylation 2
- Co-authors
- Franz Oesch (9 shared papers)Rolf Meinert (4 shared papers)Berno Tanner (3 shared papers)Jan G. Hengstler (4 shared papers)P. G. Knapstein (3 shared papers)Michael Arand (3 shared papers)Thomas Friedberg (3 shared papers)Franz Oesch (3 shared papers)
- Journals
- Carcinogenesis (3 papers)Hepatology (2 papers)International Journal of Cancer (2 papers)Value in Health (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- GermanyBrazilUnited States
In The Last Decade
Roger Becker
17 papers receiving 321 citations
Peers
Comparison fields: 5 of 59
- Pharmacology 51
- Reproductive Medicine 47
- Biochemistry 37
- Oncology 120
- Cancer Research 40
Countries citing papers authored by Roger Becker
This map shows the geographic impact of Roger Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Becker more than expected).
Fields of papers citing papers by Roger Becker
This network shows the impact of papers produced by Roger Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Becker. The network helps show where Roger Becker may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Becker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 87 | |
| 2 | 1996 | 40 | |
| 3 | 1997 | 30 | |
| 4 | 1994 | 27 | |
| 5 | 2001 | 26 | |
| 6 | 1994 | 20 | |
| 7 | The cost effectiveness of tamoxifen in the prevention of breast cancer. | 1999 | 19 |
| 8 | 1998 | 18 | |
| 9 | 1986 | 16 | |
| 10 | 1997 | 12 | |
| 11 | The heterogeneity of LDH isoenzyme patterns of human uterine sarcomas and cultured sarcoma cell lines. | 1984 | 12 |
| 12 | 1996 | 7 | |
| 13 | 1999 | 4 | |
| 14 | 1995 | 3 | |
| 15 | 2019 | 3 | |
| 16 | [On the therapy of ameloblastoma]. | 1967 | 3 |
| 17 | 1996 | 1 |
About Roger Becker
Roger Becker is a scholar working on Oncology, Molecular Biology, Pharmacology, Radiology, Nuclear Medicine and Imaging and Biochemistry, having authored 17 papers that have together received 328 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Liver physiology and pathology (3 papers), Cancer-related Molecular Pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), HER2/EGFR in Cancer Research (2 papers), Estrogen and related hormone effects (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Pharmacology (51 citations), Reproductive Medicine (47 citations), Biochemistry (37 citations), Oncology (120 citations) and Cancer Research (40 citations). Roger Becker has collaborated with scholars based in Germany, Brazil and United States. Frequent co-authors include Franz Oesch, Rolf Meinert, Berno Tanner, Jan G. Hengstler, P. G. Knapstein, Michael Arand, Thomas Friedberg, Franz Oesch, Nadja Dornhöfer and Hansruedi Glatt. Their work appears in journals such as Carcinogenesis, Hepatology, International Journal of Cancer, Value in Health and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.